Greenland Mines Ltd. Common Stock (NASDAQ:GRML - Get Free Report) was upgraded by investment analysts at Wall Street Zen to a "sell" rating in a research report issued on Saturday.
Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Greenland Mines Ltd. Common Stock in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Sell".
View Our Latest Analysis on Greenland Mines Ltd. Common Stock
Greenland Mines Ltd. Common Stock Trading Up 7.1%
Shares of NASDAQ GRML opened at $0.52 on Friday. The business has a 50-day moving average of $0.50 and a 200-day moving average of $0.43. The firm has a market capitalization of $62.51 million, a price-to-earnings ratio of -1.61 and a beta of 7.63. Greenland Mines Ltd. Common Stock has a 12 month low of $0.12 and a 12 month high of $3.91.
Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock
Hedge funds and other institutional investors have recently modified their holdings of the company. Jane Street Group LLC purchased a new position in shares of Greenland Mines Ltd. Common Stock during the 2nd quarter valued at about $26,000. XTX Topco Ltd lifted its position in Greenland Mines Ltd. Common Stock by 101.2% in the 4th quarter. XTX Topco Ltd now owns 160,569 shares of the company's stock worth $46,000 after buying an additional 80,768 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in Greenland Mines Ltd. Common Stock in the fourth quarter worth approximately $126,000. Geode Capital Management LLC boosted its stake in Greenland Mines Ltd. Common Stock by 51.8% in the fourth quarter. Geode Capital Management LLC now owns 491,832 shares of the company's stock worth $142,000 after buying an additional 167,905 shares in the last quarter. Finally, Brummer Multi Strategy AB bought a new position in Greenland Mines Ltd. Common Stock during the fourth quarter valued at approximately $175,000. 20.07% of the stock is currently owned by hedge funds and other institutional investors.
Greenland Mines Ltd. Common Stock Company Profile
(
Get Free Report)
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Greenland Mines Ltd. Common Stock, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Greenland Mines Ltd. Common Stock wasn't on the list.
While Greenland Mines Ltd. Common Stock currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.